Decades of History Tell Anything: Biotech Near $50 Set to Soar
A cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
This guide demonstrates how to leverage historical returns to shape retirement-index-fund allocations and risk management.
21,926 articlesA cash-generative biotech near $50 is drawing buyers amid a market shift toward defensible healthcare names. Here’s w...
Strategy transferred 411.48 BTC to Coinbase on May 29, 2026, a tiny slice of its huge stake. The move sparks renewed ...
XLRE has surged about 11% year-to-date, but analysts warn that rising yields could pressure capital gains while AFFO-...
Investors are zooming in on InspireMD after its Q1 2026 earnings. This detailed look breaks down the numbers, the pro...
Variant has closed a $222 million fund to back early-stage startups at the intersection of AI, crypto, and autonomy. ...
A billionaire-backed fund is quietly accumulating Robinhood stock even as executives unload shares, a move prompting ...
Mackenzie Scott’s give-spree remains rapid and largely unrestricted, reshaping modern philanthropy. This article expl...
A director at The Cheesecake Factory recently disclosed a sizable stock move. This guide breaks down what that inside...
Elon Musk says ASML has cemented its status as Europe’s top tech company, a claim that reverberates through chip equi...
Dive into Lakeland’s 2027 earnings narrative. Learn the drivers, margins, risks, and how to assess the stock for long...
Bitcoin is within roughly 9,500 blocks of a pivotal activation window that could redraw its governance playbook. The ...
Oracle confronts a fresh wave of investor anxiety as a heavy OpenAI backlog, negative cash flow, and mounting leverag...